Parkinson's Disease Clinical Trials near Philadelphia, PA
17 studies for Parkinson's Disease are recruiting at 19 sites within 50 miles of Philadelphia, Pennsylvania, according to ClinicalTrials.gov data processed .
Distances are city-level approximations. See all Parkinson's Disease trials in the US or all trials near Philadelphia.
Recruiting now
Parkinson's Disease studies enrolling near Philadelphia
- Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
NCT04373317
- Phase 4
- Ages 40 years and older
- Sex: All
- Accepts healthy volunteers
Nearest sites: Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA (Philadelphia, PA); Philadelphia MultiService Center, Philadelphia, PA (Philadelphia, PA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- Parkinson's Foundation PD GENEration Genetic Registry
NCT04994015
- Observational
- Ages 18 years and older
- Sex: All
Nearest sites: Thomas Jefferson University (Philadelphia, PA); University of Pennsylvania (Philadelphia, PA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
NCT04477785
- Observational
- Ages 30 years and older
- Sex: All
- Accepts healthy volunteers
Nearest site: University of Pennsylvania (Philadelphia, PA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Parkinson's Disease and Movement Disorders Clinical Database
NCT04997642
- Observational
- Ages 18 years and older
- Sex: All
Nearest site: University of Pennsylvania (Philadelphia, PA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Adaptive Neurostimulation to Restore Sleep in Parkinson's Disease (Aim 2)
NCT05070013
- Interventional
- Ages 18 to 80 years
- Sex: All
Nearest site: University of Pennsylvania Health System (Philadelphia, PA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications
NCT05539196
- Observational
- Ages 30 to 99 years
- Sex: All
Nearest site: University of Pennsylvania (Philadelphia, PA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Study of Biodistribution, Metabolism, Excretion and Brain Uptake11C-M503
NCT06303921
- Early Phase 1
- Ages 40 to 85 years
- Sex: All
- Accepts healthy volunteers
Nearest site: University of Pennsylvania (Philadelphia, PA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Using the EHR to Advance Genomic Medicine Across a Diverse Health System
NCT06377033
- Interventional
- Ages 18 years and older
- Sex: All
Nearest site: Penn Medicine (Philadelphia, PA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
NCT06680830
- Phase 2
- Ages 40 to 80 years
- Sex: All
Nearest site: Thomas Jefferson University Hospital (Philadelphia, PA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A
NCT06932809
- Early Phase 1
- Ages 40 to 85 years
- Sex: All
Nearest site: University of Pennsylvania (Philadelphia, PA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
NCT07174310
- Phase 3
- Ages 50 to 85 years
- Sex: All
Nearest site: University Pennsylvania Hospital (Philadelphia, PA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Early Longitudinal Imaging in the Parkinson's Progressive Marker Initiative (PPMI) Using (18F)AV-133 (PPMI AV-133 Prodromal Imaging)
NCT07265596
- Phase 2
- Ages 18 years and older
- Sex: All
Nearest site: University of Pennsylvania (Philadelphia, PA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Biofluid Research on Age-Related or Inherited Neurodegeneration
NCT07798700
- Observational
- Ages 18 years and older
- Sex: All
- Accepts healthy volunteers
Nearest site: University of Pennsylvania (Philadelphia, PA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of Buntanetap in Participants With PD
NCT07284784
- Phase 2/3
- Ages 40 to 85 years
- Sex: All
Nearest site: Abington Neurology (Willow Grove, PA)
- Distance to nearest recruiting site
- ~14 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- University of Delaware Parkinson's Disease Registry
NCT04496973
- Observational
- Ages 21 to 100 years
- Sex: All
Nearest site: University of Delaware (Newark, DE)
- Distance to nearest recruiting site
- ~36 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Online Motor Control in People With Parkinson's Disease
NCT04616508
- Interventional
- Ages 18 to 85 years
- Sex: All
- Accepts healthy volunteers
Nearest site: University of Delaware (Newark, DE)
- Distance to nearest recruiting site
- ~36 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Light Therapy Intervention in Individuals With Parkinson's Disease
NCT06916260
- Interventional
- Ages 50 to 80 years
- Sex: All
Nearest site: University of Delaware STAR Tower (Newark, DE)
- Distance to nearest recruiting site
- ~36 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
FAQ
Common questions
What is a clinical trial?
Is there compensation for joining a Parkinson's Disease clinical trial?
How do I check if I'm eligible?
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.